An update: health economics of managing multiple myeloma.

An update: health economics of managing multiple myeloma.

Item
http://www.wikidata.org/entity/Q36510055
Total cost comparison in relapsed/refractory multiple myeloma.Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysisCost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare DatabaseCost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells.
P2860

An update: health economics of managing multiple myeloma.

Item
http://www.wikidata.org/entity/Q36510055
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An update: health economics of managing multiple myeloma.
@ast
An update: health economics of managing multiple myeloma.
@en
type
label
An update: health economics of managing multiple myeloma.
@ast
An update: health economics of managing multiple myeloma.
@en
prefLabel
An update: health economics of managing multiple myeloma.
@ast
An update: health economics of managing multiple myeloma.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
An update: health economics of managing multiple myeloma.
@en
P2093
P304
P31
P356
10.1016/J.EJCA.2005.11.036
P433
P478
P577
P698